Anchored FRET sensors detect local caspase activation prior to neuronal degeneration by Figueroa, Ricardo A et al.
RESEARCH ARTICLE Open Access
Anchored FRET sensors detect local caspase
activation prior to neuronal degeneration
Ricardo A Figueroa
1,2†, Veronica Ramberg
1†, Tom Gatsinzi
1, Malin Samuelsson
1, Mu Zhang
1, Kerstin Iverfeldt
1* and
Einar Hallberg
1*
Abstract
Background: Recent studies indicate local caspase activation in dendrites or axons during development and in
neurodegenerative disorders such as Alzheimer’s disease (AD). Emerging evidences point to soluble oligomeric
amyloid-b peptide as a causative agent in AD.
Results: Here we describe the design of fluorescence resonance energy transfer (FRET)-based caspase sensors,
fused to the microtubule associated protein tau. Specific caspase sensors preferentially cleaved by caspase-3, -6 or
-9 were expressed in differentiated human neuroblastoma SH-SY5Y cells. The anchoring of the sensors resulted in
high FRET signals both in extended neurites and soma and made analysis of spatiotemporal signal propagation
possible. Caspase activation was detected as loss of FRET after exposure to different stimuli. Interestingly, after
staurosporine treatment caspase-6 activation was significantly delayed in neurites compared to cell bodies. In
addition, we show that exposure to oligomer-enriched amyloid-b peptide resulted in loss of FRET in cells
expressing sensors for caspase-3 and -6, but not -9, in both soma and neurites before neurite degeneration was
observed.
Conclusions: Taken together, the results show that by using anchored FRET sensors it is possible to detect stimuli-
dependent differential activation of caspases and to distinguish local from global caspase activation in live
neuronal cells. Furthermore, in these cells oligomer-enriched amyloid-b peptide induces a global, rather than local
activation of caspase-3 and -6, which subsequently leads to neuronal cell death.
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Introduction
In comparison with current knowledge about axon
growth and guidance, relatively little is known about the
intracellular mechanisms of neurite (axon or dendrite)
elimination and its relation to apoptosis is still not clear.
It has been suggested that axonal degeneration may
occur through a local self-destructive program, which is
distinct from the proteolytic program that mediates
apoptosis [1]. On the other hand removal of dendrites
from sensory neurons during pruning in Drosophila
melanogaster is directed by local caspase-like activity
[2]. In addition, there is evidence for the involvement of
the non-classical executioner caspase-6 in local axonal
degeneration induced by trophic deprivation of cultured
primary sensory neurons [3]. In these neurons, localiza-
tion of inactive procaspase-6 was observed in both the
axons and cell bodies, whereas procaspase-3 was primar-
ily detected in cell bodies [3]. Caspase-6 activation, as
detected by immunostaining of active caspase-6, has
been reported to occur in hippocampus and cerebral
cortex of mild, moderate, severe and very severe spora-
dic Alzheimer’s disease (AD) [4]. In human ischemia
caspase-6 translocates to the nuclei [5] where it plays a
role in nuclear lamin cleavage and subsequent chroma-
tin condensation [6]. In contrast, in AD brains immu-
nostaining of active caspase-6 was concentrated in
neurites [5], indicating a local effect in neurites.
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propagation of diffusion-mediated signaling is slower
compared to in the cytosol of a spherical cell. Local cas-
pase activation may not necessarily lead to a global acti-
vation of apoptotic processes in a cell (cf.[ 7 ] ) .I ti sa l s o
possible that different parts of a cell, such as nerve
terminals, axons or dendrites, are more vulnerable to a
particular type of toxic insult and that an apoptotic pro-
cess is initiated in a specific location followed by spread-
ing of the signal to the soma resulting in apoptotic
nerve cell death. Although there are many reliable assays
for apoptosis, they generally only distinguish between
cells that are dead or alive. The incoherent picture of
degenerative processes described in the literature calls
for techniques that allow monitoring of apoptotic pro-
gression in greater detail.
To investigate early degenerative events in neurites
and cell bodies we have developed the first model sys-
tem for spatiotemporal monitoring of caspase activation
in neuronal cells. Caspase-3, -6, and -9 have been impli-
cated both during development of the nervous system
and in neurodegenerative disorders, such as AD. Hence,
fluorescence resonance energy transfer (FRET)-based
sensors preferentially cleaved by caspase-3, -6 and -9
were designed. The sensors localize to microtubules and
are therefore highly enriched in axons/neurites. Here,
we show that our caspase sensors can in fact be used in
live cell imaging of neurite degeneration and cellular
apoptosis in an in vitro model using differentiated
human neuroblastoma SH-SY5Y cells. Our experimental
system enables monitoring of local activation of caspases
and propagation of the signal in neurites and was used
to study caspase activation induced by staurosporine,
local oxidative stress and by the AD-associated amyloid
b (Ab) peptide.
Results
Design of microtubule associated molecular FRET sensors
of activation of specific caspases
We have constructed cDNA encoding a series of sensor
molecules designed to detect activation of specific caspase
activities in neurites by a decrease in FRET (Figure 1). The
sensors (Figure 2A) are composed of two fluorophores,
enhanced cyan fluorescent protein (ECFP) and enhanced
yellow fluorescent protein (EYFP), that are separated by a
spacer containing two tandemly arranged tetrapeptide
sequences preferentially recognized and cleaved by differ-
ent caspases: DEVD, caspase-3; VEID, caspase-6; LEHD,
caspase-9 (cf. [8,9]). The tetrapeptide LEVA is resistant to
caspase cleavage and serves as a control. In order to
localize the caspase sensors to microtubules, which are
abundant in axons of neurons, they were fused to the
microtubule-associated protein tau. HeLa cells were tran-
siently transfected with plasmids encoding the caspase
sensors and their localization was studied by imaging
EYFP in live cells using confocal laser scanning micro-
scopy (CLSM). The caspase sensors clearly decorated a
filamentous network, characteristic of microtubules in
mitosis and interphase (Figure 2B). Overexpression of the
sensors did not result in any detectable toxicity and both
HeLa and SH-SY5Y cells were morphologically intact for
at least 3 days (not shown). Noteworthy, results from a
recent in vivo study have also shown that neither tau dele-
tion nor overexpression in mice affects axonal transport in
retinal ganglion cells [10]. To determine the efficiency of
FRET a quantitative acceptor bleach analysis was per-
formed (Figure 2C). All sensors displayed a FRET effi-
ciency of approximately 40 - 60%, a level of intensity that
Figure 1 Schematic illustration of local or global caspase
activation. (A) Microtubule-anchored FRET sensors for
spatiotemporal detection of caspase activation in live cells. (B)
Different scenarios (1-4) after apoptotic stimuli of differentiated
neuronal cells expressing a microtubule-anchored FRET sensor for a
specific caspase (in this study: caspase-3, -6, or -9).
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ECFP. Thus, the sensor molecules gave strong and stable
FRET signals prior to induction of apoptosis and caspase
activation. Moreover, staurosporine treated U2OS cells
expressing the caspase-6 (VEID) sensor, clearly showed
maintained localization of EYFP fluorescence to microtu-
bules after loss of FRET (Figure 2D). In contrast, ECFP
fluorescence displayed a diffuse distribution in the cell.
This clearly demonstrates that loss of FRET is a conse-
quence of VEID-specific cleavage and is not due to any
other proteolytic event.
Loss of FRET and proteolytic cleavage of sensor
molecules in differentiated neuroblastoma cells
undergoing apoptosis
Differentiated human neuroblastoma SH-SY5Y cells
were transfected with plasmids encoding the different
FRET sensor molecules. The experiments were started
by addition of staurosporine, one of the best inducers of
apoptosis in many different cell types, after which the
cells were imaged by FRET microscopy for 8 hours in
order to monitor changes in FRET. In cells expressing
sensors for caspase-3 (DEVD) a drop in FRET was
detectable before retraction of neurites and the FRET
signal continued to decrease for 20 min (Figure 3A).
The decrease in FRET signal from the caspase-9
(LEHD) sensor was completed in 10 min (Figure 3A).
Cells expressing the control FRET sensor, containing
the engineered non-cleavable tetra-amino acid motif
(LEVA), did not show any alteration in FRET signal
within this time frame (Figure 3A) although massive
apoptotic morphological changes were evident (not
shown).
Western blot analysis, using anti-GFP antibodies, of
extracts of SH-SY5Y cells expressing the caspase-3
(DEVD) or control (LEVA) FRET sensors displayed a spe-
cific band with an apparent molecular weight of 130 kDa
(Figure 3B). After 3 hours of incubation with 10 μM staur-
osporine a specific band at approximately 100 kDa
appeared in cells expressing the caspase-3 (DEVD) sensor.
EYFP and ECFP both have an expected size of 27 kDa,
whereas the 441 amino acid long tau isoform in human
brain tissue has been reported to migrate with an apparent
molecular weight of approximately 74 kDa [11]. Thus, the
~100 kDa cleavage product is consistent with the expected
migration of the EYFP-Tau fragment (~27 kDa + ~74
kDa) from caspase-dependent cleavage of the DEVD
motif. In support of this is the fact that the ~100 kDa
band was absent from staurosporine treated cells expres-
sing the control (LEVA) sensor. In addition, the presence
of caspase inhibitors prevented staurosporine-induced
appearance of the ~100 kDa band (Additional file 1, Figure
S1). The results demonstrate that decreased FRET inten-
sity in apoptotic SH-SY5Y cells expressing the FRET sen-
sor was correlated to caspase-dependent proteolysis of the
sensor molecule.
Detection of local caspase activation in live
neuroblastoma cells
When we monitored the caspase activity in differentiated
neuroblastoma cells expressing the caspase-6 (VEID) sen-
sor treated with staurosporine we observed that the
FRET intensity first decreased in the cell body and only
5-10 min later decreased in the neurites (Figure 4A and
Additional file 2, Movie). Statistical analysis of a larger
data set showed that the spatiotemporal difference was
Figure 2 Design of FRET sensor molecules for detection of
local activation of specific caspases.( A) Schematic outline of
FRET sensor molecules. ECFP and EYFP are connected with different
spacer sequences containing two tandemly arranged tetra-amino
acid cleavage sequences preferentially cleaved by different caspases
(as specified) or a non-cleavable control tetra-amino acid LEVA
sequence. The microtubule binding Tau protein is fused to the C-
terminus of EYFP to target the sensors to microtubules. (B)
Distribution of the caspase-3 (DEVD) sensor to microtubules of
mitotic (left) and interphase (right) HeLa cells. (C) Quantitative
acceptor bleaching experiments in differentiated neuroblastoma SH-
SY5Y cells expressing different caspase sensors, showing
approximately 50% increase in ECFP fluorescence after bleaching of
EYFP. (D) U2OS cells expressing FRET sensors for caspase-6 (VEID)
treated with 10 μM staurosporine. The apoptotic cell (star) showed
maintained localization of EYFP fluorescence to microtubules (right
cell), in contrast to ECFP fluorescence, after loss of FRET.
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decrease in FRET signal was significantly larger in cell
bodies as compared to neurites at 5 min (p < 0,05), 10
min (p < 0.01) and 15 min (p < 0.05). This demonstrates
the ability of the sensor molecule to monitor spatiotem-
poral changes in caspase activation in live cells in a
reproducible way. Next, we decided to determine
whether local caspase activation could also be detected
using other sensors. For this, local damage was induced
in differentiated SH-SY5Y cells co-expressing the cas-
pase-3 (DEVD) sensor and the mitochondrially-targeted
photosensitizer KillerRed [12]. Illumination of selected
KillerRed containing mitochondria with 561 nm light
made it possible to initiate apoptosis locally via the
intrinsic pathway resultingi nal o c a l i z e dl o s so fF R E T
signal (Figure 5). After local stimulation of selected mito-
chondria in a part of a neurite proximal to the cell body
the intensity of the FRET signal from the caspase-3
(DEVD) sensor decreased throughout the targeted neur-
ite and in the cell body, but only later decreased in neur-
ites extending from other parts of the cell body. Thus,
these results show that it is possible to visualize spatio-
temporal differences in caspase activation in different
parts of the cell using our FRET sensors.
Detection of differential caspase activation in live
neuroblastoma cells treated with Ab1-42 peptide
Next, we investigated if it was possible to monitor speci-
fic caspase activation induced by Ab1-42 and to deter-
mine where in the cell this apoptotic signal is initiated.
Differentiated SH-SY5Y cells expressing FRET sensor
molecules for different caspases were exposed to a pre-
paration enriched in Ab1-42 oligomers (Additional file 3,
Figure S2). Decreased FRET intensities for the caspase-3
(DEVD) and caspase-6 (VEID) sensors were observed
(Figure 6A), that was accompanied by proteolysis as evi-
denced by a corresponding fragmentation of the caspase-
6 (VEID) sensor (Figure 6B). As shown by the maintained
localization of EYFP fluorescence to microtubules after
the decrease in FRET intensity (Figure 6C), Ab1-42
induced cleavage of the engineered VEID sequence ahead
of any possible proteolysis that might affect localization.
Figure 3 Monitoring of FRET sensor molecule cleavage in neuronal cells undergoing apopotosis. Transfected and differentiated SH-SY5Y
cells were treated with 10 μM staurosporine to induce apoptosis. (A) FRET intensity time-lapse imaging of FRET sensors. Time is indicated on
top. The frame before the initial drop in FRET intensity was chosen as zero time point for the caspase-3 (DEVD) and -9 (LEHD) sensors, whereas
initiation of neurite retraction was chosen as zero time point for the control (LEVA) sensor. Corresponding graphs show the quantitative change
in FRET intensity. The FRET signal decreased in cells expressing the caspase-3 (DEVD), or -9 (LEHD) sensors, but not in cells expressing the control
(LEVA) sensor. The gray dashed curve corresponds to the right cell (#1), which has a different zero time point than the left cell (#2) in the LEHD
time-lapse experiment. (B) Western blot analysis using anti-GFP antibodies of FRET sensor molecules in extracts of cells expressing the caspase-3
(DEVD) sensor or the uncleavable control (LEVA) sensor incubated for 3 hours in the absence or presence of 10 μM staurosporine.
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enable detection of local changes (see Figure 4 and 5) the
caspase-3 (DEVD) and caspase-6 (VEID) sensors dis-
played decreased FRET intensity throughout the cell.
Thus, our results suggest that the Ab1-42 peptide
induces global activation of caspase-3 and caspase-6 in
these cells. Interestingly, the FRET intensity from the cas-
pase-9 (LEHD) sensor remained high even after morpho-
logical signs of cell death including neurite retraction
(Figure 6D). This suggests that neurodegeneration
i n d u c e db ye x p o s u r et on o n - f i b r i l l a rf o r m so fA b1-42 is
not dependent on caspase-9 and that different caspase
activities clearly can be distinguished by our sensors.
Discussion
Selective elimination (degeneration or retraction) of
axons and dendrites, without death of the neuron is
important during development of the nervous system in
order to refine synaptic connections. However, axon
elimination, as well as apoptosis [13,14], also occurs in
many neurological diseases or as a consequence of neu-
ronal injury (reviewed by [1,15]). Axonal degeneration
involves a rapid breakdown of the axonal cytoskeleton
caused by enzymatic degradation of neurofilaments. A
process termed dying-back degeneration (or Wallerian-
like degeneration) has been described in a variety of
neurological disorders and is characterized by initial
degeneration of distal regions of long axons followed by
distal-to-proximal progression. In many neurodegenera-
tive diseases, including AD, axonal and dendritic atro-
phies are observed, (e.g. [16]). Such neuritic atrophies
will most likely contribute significantly to the clinical
symptoms and occur prior to or in the absence of neu-
r o n a ld e a t h .I nam o u s em o d e lo fA Din vivo imaging
Figure 4 Spatiotemporal differences in activation of caspase-6 in staurosporine treated neuroblastoma cells. Differentiated SH-SY5Y cells
expressing the caspase-6 (VEID) sensor molecule treated with 10 μM staurosporine were monitored by FRET time-lapse microscopy. (A) Images
at 10 min intervals from a FRET time-lapse experiment. Time points relative to the FRET intensity change of the left cell are indicated at the top.
The frame before the initial drop in FRET intensity was chosen as zero time point. The relative FRET intensity is shown in graphs corresponding
to the left and right cell, respectively. The different graphs are from cell soma (blue squares); neurite 1 (red dots); neurite 2 (green triangles);
neurite 3 (red rhombuses); neurite 4 (green crosses). Note the localized loss of FRET signal in the soma, which appeared earlier than in neurites.
(B) Statistical analysis of spatiotemporal differences in FRET intensity of cell bodies (left, blue) and neurites (right, red) from different experiments
(n = 8; mean ± S.E.M.). The FRET signals in cell bodies were significantly lower than the FRET signals in neurites at 5 min (p < 0.05), 10 min (p <
0.01) and 15 min (p < 0.05).
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in AD brain, can indeed induce breakage of axonal and
dendritic branches [17].
Here, we describe the development and characteriza-
tion of new FRET based sensors for spatiotemporal ima-
ging and analysis of caspase activation in relation to
neurite degeneration and neuronal cell death. A full-
length tau moiety was added to the FRET sensors both
to mediate association to microtubules in neurites and
thus increase signal intensity as well as to restrict diffu-
sion of the sensors to allow monitoring progression of
the apoptotic signal in a spatiotemporal manner (cf.
Figure 1). As expected our caspase sensors localize to
the cytoskeleton when expressed in non-neuronal
(HeLa) cells and also to the microtubule of the neurites
when expressed in differentiated neuronal cells. FRET
studies in differentiated SH-SY5Y cells exposed to staur-
osporine verify the sensors as early markers of apoptosis
occurring prior to neurite retraction and any other mor-
phological changes could be detected. Caspase activation
was measured as loss of FRET and it was confirmed, by
western blot analysis of sensor fragmentation, to corre-
spond to cleavage between EYFP and ECFP where the
caspase cleavage sites are localized.
In this study we focus on three different caspases; cas-
pase-3, -6, and -9. Caspase-9 is the initiator caspase asso-
ciated with the mitochondrial or intrinsic apoptotic
pathway [18]. Proapoptotic signals stimulating release of
cytochrome c from mitochondria that promotes oligo-
merization of apoptotic peptidase activating factor 1
(Apaf-1), will lead to recruitment and activation of cas-
pase-9. Caspase-9 null mice die perinatally and show a
similar phenotype as mice with deletion of Apaf-1 or cas-
pase-3 genes, including enlarged and deformed brains
[19,20]. This clearly indicates the importance of the
intrinsic apoptotic pathway during development of the
nervous system. Caspase-9 has also been proposed to be
activated by an alternative pathway: It has been shown
that endoplasmic reticulum (ER) stress can activate cas-
pase-9 in the absence of cytochrome c and Apaf-1
[21,22]. Interestingly, Ab peptides have been shown to
induce apoptosis mediated by ER stress [23]. Further-
more, increased levels of active caspase-9 have been
detected in AD brain [15,24]. Also, in a recently pub-
lished study [25] caspase-9 and the intrinsic apoptotic
pathway was suggested to be involved in non-apoptotic
caspase-3 activity in dendritic spines in Tg2576-APPswe
mice. This activity correlated with the onset of memory
deficits in these mice. Therefore, caspase-9 has been pro-
posed to be involved not only in developmental apoptosis
of neuronal cells but also in neurodegenerative disorders
such as AD. Caspase-3 is the major executioner caspase
and can be activated once an initiator caspase, like cas-
pase-9, is activated. Caspase-6 is also often classified as
an executioner caspase since it cleaves the nuclear lamin
proteins during apoptosis [6]. However, proteomics
Figure 5 Detection of caspase activity induced by local photo activation of mitochondrial KillerRed. Differentiated neuroblastoma cells
coexpressing mitochondrially targeted KillerRed and the caspase-3 (DEVD) sensor molecule. (A) Images of mitochondrial KillerRed fluorescence,
with corresponding phase contrast image, before (circled) and after photo-activation in selected mitochondria. (B) Corresponding FRET intensity
time-lapse images. Time points (see Figure 3) relative to the FRET intensity change are indicated at the top. The frame before the initial drop in
FRET intensity was chosen as zero time point. The graph displays relative FRET intensity in the cell body (blue squares), neurite 1 (red dots),
neurite 2 (green triangles) and neurite 3 (magenta rhombuses).
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expressing FRET sensor molecules were treated with oligomer-enriched preparations of Ab1-42 at concentrations known to induce apoptosis. (A)
FRET intensity time-lapse imaging of the caspase-3 and -6 sensors in cells treated with 20 μM oligomer-enriched Ab1-42. Time is indicated on
top. The frame before the initial drop in FRET intensity was chosen as zero time point for the caspase-3 (DEVD) and -6 (VEID) sensors, whereas
initiation of neurite retraction was chosen as zero time point for the control (LEVA) sensor. Corresponding graphs show the quantitative change
in FRET intensity in the soma (blue squares) and neurites (red dots). (B) Western blot analysis using anti-GFP antibodies, of FRET sensor
molecules in extracts of cells expressing the caspase-6 (VEID) sensor incubated for 18 hours in the absence (lane 1) or presence (lane 2) of
10 μM of oligomer-enriched Ab1-42 preparation. Staurosporine treatment (2 μM, 18 h) is shown for comparison. (C) Image of cell expressing the
caspase-6 (VEID) sensor treated with oligomer-enriched Ab1-42 showing loss of FRET signal, but maintained distribution of EYFP fluorescence
along microtubules. ECFP fluorescence was diffuse. (D) FRET intensity time-lapse imaging of the caspase-9 (LEHD) sensor and corresponding
quantitative graphic representation. Note the maintained high FRET intensity before and after neurite retraction, which was chosen as zero time
point.
Figueroa et al. Molecular Neurodegeneration 2011, 6:35
http://www.molecularneurodegeneration.com/content/6/1/35
Page 7 of 11analysis showed that nearly half of identified neuronal
caspase-6 targets were cytoskeleton-associated, indicating
that caspase-6 most likely can function also before death
signals reach the nucleus [26]. In addition, recent studies
have implicated caspase-6 in axonal degeneration not
linked to apoptotic cell death [3].
We evaluated the performance of the caspase sensors in
differentiated neuroblastoma cells treated with staurospor-
ine. We observed a significant decrease in FRET signal in
cells expressing caspase-3 and -9 sensors, but not in cells
expressing the non-cleavable control (Figure 3). Stauros-
porine is a non-specific inhibitor of protein kinases and is
one of the best inducers of apoptosis in different types of
cells, including neuroblastoma [27,28]. Although the
mechanism by which staurosporine induces apoptosis is
not well known, the mitochondrial pathway has been
shown to be involved [29,30], consistent with our results.
For caspase-3 and -9, we could not detect any time differ-
ence in the loss of FRET in neurites and soma. This indi-
cates that staurosporine may induce a global activation of
these two caspases in neuronal cells. However, when the
loss of FRET in cells expressing the caspase-6 sensor was
analyzed we observed a clear and significant delay in the
neurites compared to the cell bodies (Figure 4). This indi-
cates a difference in staurosporine-induced apoptotic sig-
naling in axons/dendrites compared to the cell bodies. A
previous study has indicated a spatiotemporal difference in
caspase-3 compared to caspase-6 activation [31]. In undif-
ferentiated SH-SY5Y cells exposed to staurosporine cas-
pase-6 activation, monitored by the appearance of a lamin
B1 fragment in western blot analysis, was considerably
delayed compared to cleavage of caspase-3 substrates [31].
Thus, it may be speculated that staurosporine induces a
delayed activation of caspase-6 that is initiated in the cell
body and thereafter is spread to the neurites.
The ability to detect caspase activation at sub-cellular
resolution was further established using a co-expressed
mitochondrial photosensitizer (Killer red) [12], which
enabled induction of apoptosis locally in the cell via the
intrinsic pathway. We observed that if caspase-3 activation
was initiated in one of the neurites the signal was quickly
transferred to the cell body but not to other neurites
(Figure 5). The other neurites degenerated as well after the
cell had been exposed to the death stimuli in spite of the
delayed caspase-3 activation.
Finally, we used differentiated neuroblastoma cells
expressing caspase sensors to analyze the effect of the Ab
peptide on apoptotic signaling. Apoptotic signaling is
believed to play an important role in a number of neuro-
logical disorders, including AD [32]. If caspase activation
is crucial for the progression of AD pathology it is impor-
tant to learn how the activation occurs, where in the neu-
ron this process takes place, and whether or not it will
result in neuronal cell death. Ab is a hydrophobic peptide
generated by sequential proteolytic cleavage of amyloid
precursor protein (APP) by b-a n dg-secretase and is the
leading candidate for activation of apoptotic mechanisms
in AD [7,33]. Ab is highly prone to aggregate and in the
brain it is found in different forms ranging from mono-
mers and non-fibrillar aggregates, termed oligomers, to a
highly fibrillar form. Recent evidences suggest that it is
the diffusible Ab oligomers that have the most toxic
properties [34,35]. Ab oligomers have also been shown to
bind to synaptic sites [36], which may be important for
early synaptic failure observed in AD (cf. [37]). Further-
more, Ab has been proposed to have a local effect on
neurites causing degeneration and neuritic apoptosis
using compartmented cultures of hippocampal neurons
[38]. In the present study we have exposed the cells to a
preparation enriched in oligomer-enriched forms of Ab
with non-detectable levels of fibrils. Ab exposure resulted
in activation of caspase-3 and -6, but we could not detect
any specific spatiotemporal effect of the peptide. Thus,
our results suggest that in these neuronally differentiated
cells there is no part of the cell that is more vulnerable to
insult and that Ab rather induces global caspase activa-
tion. Because the caspase-9 sensor resisted proteolysis,
the intrinsic pathway may play a less important role in
Ab1-42 induced apoptosis of these cells. Most interest-
ingly, it was recently shown in a mouse model that cas-
pase activation precedes and leads to tangles (i.e., a
characteristic neuropathological feature in AD).
Evidences also indicated that caspase-3 and -6 were acti-
vated in the tangle positive cells [39].
In conclusion, we show that the anchored caspase sen-
sors localize to the cytoskeleton, that they are differentially
cleaved depending on stimuli and that they can be used to
detect local caspase activation and to follow the spreading
of caspase activation from one part of the cell to another.
Under the conditions used in this study we could not
detect any specific spatiotemporal effect of Ab on caspase
activation. Caspase-3 and -6, but not -9, were activated
both in soma and in neurites. It will be interesting to use
the anchored FRET sensors in experiments designed to
cause retraction and loss of synaptic contacts without
causing cell death. This is indeed a promising new tool in
research on AD and other neurodegenerative conditions.
Materials and methods
Gene construction
To construct the localized caspase sensors, EYFP was
amplified from the EYFP-C1 plasmid (BD Biosciences)
using the following primers: forward, 5’-TATTA-
GATCTCATGGTGAGCAAGGGCGA-G-3’,r e v e r s e ,
5’-ACGTGAATTCCTTGTACAGCTCGTCCATGC-3’.
The resulting PCR product was digested with BglII-
EcoRI, gel-purified and ligated into the BglII-EcoRI of
the ECFP-C1 vector (BD Biosciences). The longest
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from the pBThtau40 plasmid (kindly provided by Dr.
Jacek Biernat, Max-Planck-Gesellschaft) using the fol-
lowing primers: forward, 5’-ATTAGAATTCATGGCT-
GAGCCCCGCCAG-3’, reverse, 5’-ATGCGGATCCGT
GATCACAAAC-3’. The resulting PCR product was
digested with EcoRI-BamHI, gel-purified and ligated
into the EcoRI-BamHI of the ECFP-EYFP vector. To
create cleavage sites for caspase-3, -6 and -9 plus an
un-cleavable control sequence single stranded sense
32-mers; 5’-CCGGAGCAGATGAGGTCGATGCC-
GATGAGGTC-3’ ( c a s p a s e - 3 ,D E V D x 2 ) ,5 ’-CCGGAG-
CAGTCGAGATAGATGCCGTAGAGATC-3’ (caspase-
6, VEIDx2), 5’-CCGGAGCACTGGAGCACGATGCC
CTGGAGCAC-3’ (caspase-9, LEHDx2) and 5’-CCGGA
GCACTGGAGGTCGCCCTGGAGGTCGCC-3’ (con-
trol, LEVAx2) were annealed to complementary anti-
sense 32-mers; 5’-GATCGACCTCATCGGCATCGAC
CTCATCTGCT-3’ (caspase-3), 5’-GATCGATCTC-
TACGGCATCTATCTCGACTGCT-3’ (caspase-6), 5’-
GATCGTGCTCCAGGGCATCGTGCTCCAGTGCT-3’
(caspase-9) and 5’-GATCGGCGACCTCCAGGGC-
GACCTCCAGTGCT-3’ (control) generating double
stranded DNA with caspase cleavage sites in tandem
and BspEI-BglII sticky ends that were ligated into the
BspEI-BglII of the ECFP-EYPP-Tau vector. One base
was changed in the BglII site in the linker region to
facilitate restriction analysis.
Cell culture and transfection
HeLa (CCL-2, American Type culture Collection) and
U2OS cells (ATCC-HTB-96, LGC standards) were cul-
tured in Dulbecco’s Modified Eagle Medium (DMEM, Invi-
trogen) supplemented with 10% fetal bovine serum (FBS,
Invitrogen), 100 U/ml penicillin and 100 μg/ml streptomy-
cin (PEST, Invitrogen). Human neuroblastoma SH-SY5Y
cells (CRL-2266, ATCC) were cultured in DMEM/F12 sup-
plemented with 10% FBS, 100 U/ml PEST. The cells were
maintained in a humidified 5% CO2 atmosphere at 37°C.
Cells were transfected using FuGENE HD (Roche). In live
cell imaging experiments cells were seeded on to glass
cover slips prior to differentiation. The neuroblastoma cells
were differentiated with 10 μM retinoic acid (RA) for three
days before transfection after witch cells were incubated
for one day prior to the experiment. For western blot ana-
lysis cells were seeded at a density of 25.000 cells/cm
2 into
Petri dishes (Nunc, Denmark). The following day the cells
were treated with 10 μM RA for 72 h. After 24 h, the cells
were transfected with plasmids encoding different caspase
sensors and incubated for 48 h prior to the experiment.
Preparation of Ab1-42 enriched in oligomers
Ab1-42 (American peptide) was dissolved in hexafluoroi-
sopropanol (HFP) to remove any preexisting structures
in the lyophilized stocks and was then stored at -70°C.
The peptide was prepared to obtain a solution enriched
in oligomeric, but devoid of fibrillar, forms of the peptide,
cf. [40]. The oligomer-enriched Ab1-42 was prepared
freshly before each experiment. HFP was allowed to eva-
porate from the tube using speedvac system for 5 min at
room temperature. Thereafter, Ab1-42 was dissolved in
dimethyl sulfoxide (DMSO) to a concentration of 5 mM.
Subsequently, phosphate bovine saline (PBS) was added
t og i v eaf i n a lA b1-42 concentration of 100 μM. Finally,
the preparation was vigorously vortexed at room tem-
perature for 10 min, whereafter Ab1-42 was allowed to
aggregate by incubation for 24 h at 4°C at 200 rpm. Ana-
lysis of the Ab preparation was made by western blot and
Thioflavin T assay (Additional file 2, Figure S2).
Imaging
Imaging was performed on a Leica TCS-SP laser scanning
confocal microscope (Leica, Heidelberg, Germany) with a
63.0 × 1.32 oil immersion objective using a 442 nm
10 mW HeCd laser, 488 nm laser line of a 40 mW Ar-
laser and 561 nm laser line of a yellow diode pumped
solid-state 50 mW laser. Emission was collected between
455-505 nm (CFP), 515-575 nm (YFP and FRET), and
580-650 nm (KillerRed) using a long pass dicroic mirror
(LP) 450 for CFP and FRET, LP500 for YFP and triple
dicroic 488/561/633 for KillerRed. The laser lines were
scanned sequentially to minimize bleed through. Induction
of KillerRed phototoxic effect was achieved by scanning a
region of the cells using the 561 nm laser line. Live cell
imaging was performed by mounting cells in sealed cham-
bers with serum free media buffered with HEPES. In
experiments with staurosporine and Ab, the agent was
added to the media when mounting the cells. Temperature
was maintained at 37°C using the Cube and Box micro-
scope incubator system (Live Imaging Services). Projec-
tions of image stacks were used for quantification. Images
were processed and quantified using ImageJ (Rasband, W.
S., Image J, U. S. National Institutes of Health, Bethesda,
Maryland, USA, http://rsb.info.nih.gov/ij/, 1997-2009). To
acquire the ratio-metric images the intensity in the FRET
channel was divided by the intensity in the CFP channel.
A pseudo-color was applied and adjusted to visualize the
changes in FRET. For graphic representation, images were
segmented in a semi-automatic process rendering soma
and neurite regions of interest. Values were normalized in
relation to the mean value prior to changes in FRET. The
last frame before decreased FRET could be detected in
each individual experiment was chosen as zero time point
to enable alignment of graphs from different experiments.
At least three individual experiments were performed.
Spatiotemporal studies of FRET signals in neurites and
soma were statistically analyzed using unpaired two-tailed
Student’ sT - t e s t .
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For western blot analysis of caspase sensor fragmentation
human neuroblastoma SH-SY5Y cells treated with Ab1-
42 or staurosporine were harvested as follows: First, the
cells were washed twice with PBS containing 0.7 μg/ml
aprotinin (from bovine) and 0.8 mM PMSF. Thereafter,
the cells were lysed in lysis buffer (150 mM NaCl,
50 mM TrisCl, 1 mM EDTA, 1% NP-40), containing
complete protease inhibitor cocktail, for 20 min at 4°C.
In order to remove cell debris the lysate was centrifuged
at 10 000 g for 5 min at 4°C. The supernatant was then
used for western blot analysis. 30 μg protein from each
separate sample was separated by electrophoresis on 8%
SDS-polyacrylamide gels and subsequently transferred to
polyvinyldine difluoride membranes at 350 mA for 3 h.
T h em e m b r a n ew a sb l o c k e di nP B S ,c o n t a i n i n g5 %d r y
milk (w/v) and 0.1% Tween, for 1.5 h, followed by over
night incubation at 4°C with primary rabbit polyclonal or
mouse monoclonal anti-GFP antibody (1:1000) (R&D
systems). Finally, secondary horseradish peroxidise-
coupled donkey anti-rabbit or sheep anti-mouse antibo-
dies (1:5000) were incubated for 1 h at room temperature
and the detected proteins were visualised by chemilumi-
nescence using Western LightingTM-PLUS-ECL kit (Per-
kin Elmer, Netherlands). All western blot reagents were
from GE Healthcare or Bio-Rad Laboratories.
Additional material
Additional file 1: Figure S1 Inhibition of staurosporine-induced
FRET-sensor cleavage by caspase inhibitors. western blot analysis
using anti-GFP antibodies of FRET sensor molecules in cells expressing
the VEID sensor in the presence or absence (1 h pretreatment) of the
caspase inhibitors Z-VAD-FMK (Promega) or Z-Asp-CH2-DCB (PeptaNova)
followed by 1 h staurosporine treatment.
Additional file 2: Movie. Spatiotemporal difference in activation of
caspase-6 in staurosporine treated neuroblastoma cells.
Differentiated SH-SY5Y cells expressing the caspase-6 (VEID) sensor
molecule treated with staurosporine were monitored by FRET time-lapse
microscopy. One frame every 5 min.
Additional file 3: Figure S2 Analysis of oligomer- and fibril-enriched
preparations of Ab1-42. (A) Representative western blot showing high
levels of fibrilar Ab in the oligomeric/fibrillar preparation (lane 1) and the
absence of Ab fibrils in the oligomeric preparation (lane 2). The Ab
samples were separated by SDS-PAGE and both stacking- and separation
gel was analyzed by western blot using 6E10 antibodies (Signet
Laboratories). (B) Statistical analysis of Thioflavin T (T3516, Sigma)
fluorescence in oligomeric/fibril-enriched Ab preparations (fAb; open bar)
and oligomer-enriched Ab preparations (oAb; filled bar). Ab samples were
analyzed in phenol red-free medium and according to the manufacturer’s
instructions. The data represent mean ± SEM for three independent
experiments. A.U., arbitrary units. *p < 0.05 significantly different from fAb.
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